https://www.selleckchem.com/pr....oducts/gs-441524.htm
Acute myeloid leukemia (AML) is a malignant clonal hematopoietic stem cell disease. Although there are many therapeutic options, it is still an incurable hematological malignancy. Moreover, the prognosis of AML is closely related to its cytogenetics and molecular biology. The DEK/CAN fusion gene formed by t (6;9)(p23;q34) occurs with an incidence of 1-5% in adult patients with AML usually indicates a poor prognosis. Hematopoietic stem cell transplantation can prolong the disease-free survival rate of patients with AML positive for DEK
Aimer
Commentaire
Partagez
